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Material and Methods 
 
Transient middle cerebral artery occlusion: Animals were anesthetized (2% 
isoflurane/ 70% NO2/ 30%O2), body temperature maintained 37ºC, and left middle 
cerebral artery (MCA) exposed for transcranial Laser Doppler flowmetry (TSI, Inc) 
according to previously published methods (1-4). A blunted suture (6.0-gauge nylon, 12 
mm) was advanced to block the MCA (>80% reduction relative to baseline blood flow) by 
surgeons blinded to condition, between 8-14:00 hours, with 10 mice/surgeon/day 
maximum, with minimum of 2 duplicate experimental days for each outcome measure. 
All surgical data, including inclusion/exclusion numbers are available upon request and 
summarized in the Methods section of the main text. Animals were placed in an 
incubator (34ºC), re-anesthetized after 60 minutes, and suture withdrawn. Flowmetry 
confirmed reperfusion (CBF >50% baseline). Animals were monitored and those not 
meeting blood flow criteria will be removed. Neurological deficit was scored on an 
established scale of 0-4 (1).  
 
In vitro and In vivo Infarct Volume Assessment: 
 Cresyl violet/stereology: Brains were extracted and cryoprotected by immersion in 
15% sucrose solution for 24 hr, followed by immersion in 30% sucrose solution until 
sectioning. Coronal sections (40 um) were serially cut on a freezing microtome and 
stained with cresyl violet (5). 40x digital images of the slides were obtained using whole 
slide imaging (Nanozoomer 2.0HT, Hamamatsu Photonics, Hamamatsu-shi, Japan). 
Infarct volumes were quantified by a blinded observer in Stereo Investigator stereology 
software (Microbrightfield Biosciences, Williston, VT) using the Cavalieri Estimator 
Probe, which calculates an estimation of a volume in a user-defined region of interest. 
Infarcted tissue was defined as areas with pyknotic cells.  
 TTC: For infarct volume assessment, animals were perfused, brains removed and 
sectioned into 1.0 mm thick coronal sections. Brains were then placed in 2,3,5-Triphenyl 
Tetrazolium Chloride (TTC) solution, which demarcates mitochondrial dysfunction, an 
indicator of neuropathology, and quantified by an observer blinded to experimental 
treatment using Image J software (NIH, v1.47f) (1, 6).  
 MRI: For the in vivo infarct volume assessment, magnetic imaging resonance (MRI) 
was conducted using a 7-Tesla small animal MRI system (Agilent (Varian) Inc., Palo 
Alto, CA) with a 40 mm. Millipede coil and a 400mT/m gradient coil set. Under 
anesthesia (1-2% isoflurane/ 70% NO2/ 30%O2), animals were placed supine with 
respiratory sensor head first and centered with respect to the center of a RF coil. 
Through the imaging session, animals were monitored for respiration rate (SA 
Instruments, Stony Brook NY). For volume measurements of brain, high-resolution T2-
weighted fast spin echo (FSE) axial images were acquired on the entire brain. The 
imaging parameters were: TR/TE = 2500/60 msec., FOV = 25.6x25.6 mm., matrix size = 
256x256, slice thickness = 1 mm., no gap, 8 averages, affording 100 µm. in-plane 
resolution and a total scan time of 10 minutes and 45 seconds. Hyper-intense areas, 
reflecting high content of water, such as edema and dilated/expanded ventricles, were 
calculated on the selected T2-weighted images by manual segmentation using ImageJ. 
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The calculated hyper-intense areas were multiplied by slice thickness (1 mm.), for a total 
of 15 slices, to obtain total volume of injury.  
 
B cell isolation and intravenous injection: Using magnetic B cell isolation kits 
(STEMCELL), donor B cells were isolated from spleens of naïve adult male C57Bl/6J 
(Jackson Labs) mice or hCD20- transgenic mice. 5x106 B cells were labeled with a 
fluorescent proliferation dye (e450; eBioscience) and intravenous injected into recipient 
mice and sacrificed according to timelines shown in Fig. 1. Peripheral migration of B 
cells into spleen and cervical lymph nodes was assessed using flow cytometry. Brains 
were extracted and further postfixed overnight in 4% PFA at 4 °C, transferred to PBS + 
0.01% sodium azide  and stored at 4 °C until embedding. 
 
Flow cytometry: A general leukocyte survey was performed on cells from the spleen, 
processed into a single cell suspension and 1x106 bulk cells were used for quantification 
using fluorescent antibodies specific to leukocytes (CD45-APC-Cy7), B cells (CD19-
Alexa 700), monocytes/macrophages (CD11b-PE), neutrophils (GR1-FITC), NK cells 
(NK1.1-Percp 5.5), and T cells (TCR-PE-Cy5; CD4-PacBlue). Cells were incubated for 
30 min. at 4°C and subsequently washed and fixed in 1% paraformaldehyde (Electron 
Microscopy Science, Harfield PA). Flow cytometric data were acquired using a BD FACS 
Canto using FACS Diva 6.0 software. FlowJo 9.0 software (Tree Star, Ashland, OR) was 
used to subset leukocytes according to gating strategy.  
 
Mixed Cortical Cultures: Cortical and hippocampal tissue from postnatal day 0-2 
YFP2.2 or C57Bl/6J pups was digested using 0.25% Trypsin-EDTA (Hyclone) to isolate 
cells to be plated at density of 1.8-2.0x106 cells per well in a 6-well culture dish in mixed 
cortical media (1x DMEM (Corning), 10% fetal bovine serum (Gemini), 1% sodium 
pyruvate (Corning), and 100μg/mL Primocin (InvivoGen)) until confluent (minimum 7 
days). Naïve B cells were isolated via negative selection EasyStep magnetic beads 
(Miltenyi Biotec) from spleens of adult 8-12 week old male C57BL/6 mice. For B cell pre-
treatment, B cells were co-cultured for 4 days prior to oxygen-glucose deprivation  
(OGD) in 0.05:1.0, 0.1:1.0, or 1.0:1.0 B cell:CNS cells ratios. In B cell post-treatment, B 
cells were co-cultured for 4 days immediately after OGD. OGD was induced for 2 hours 
by exposure to 0.1% O2 in a hypoxic chamber with serum/glucose-free HBSS (Cellgro). 
Following a 3-day post-OGD recovery, neuronal protection was assessed using MAP2+ 
immunofluorescent staining, and confocal microscopy (Zeiss LSM 880 Inverted 
microscope, 10x, 4 images/well). Cells per image were quantified using the counter tool 
in Photoshop CS6, normalized to non-B cell control, and analyzed by one-way ANOVA, 
Bonferroni post-hoc (Graph-pad Prism7).  
 
Sample Preparation for Serial Two-photon Tomography: B cell migration into the 
brain was assessed using 3D serial two-photon tomography (STPT)(7) of the entire brain 
volume (TissueCyte 1000 microscope, TissueVision, Cambridge, MA). To prepare 
samples for STPT, a 4.5% (w/v) agarose (Type 1A, low EEO, Sigma Catalog #A0169) 
solution in 50 mM phosphate buffer was prepared and oxidized by adding 10 mM NaIO4 
(Sigma Catalog #S1878) and stirring gently for 2 to 3 hours in the dark. The agarose 
solution was filtered with vacuum suction and washed 3 times with 50 mM phosphate 
buffer. The washed agarose was resuspended in the appropriate volume of phosphate 
buffer to make a 4.5% agarose solution. The oxidized agarose solution was heated to 
boiling in a microwave, then transferred to a stirring plate and allowed to cool to 60-65 
°C. Brains were embedded by filling a cryoembedding mold (VWR Catalog #15560-215) 
with oxidized agarose, placing the filled mold on a flat ice pack, and then quickly 
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submerging the brain using forceps into the bottom of the block with the cerebellum 
touching the bottom of the block (olfactory bulbs facing upward). The agarose block was 
allowed to fully solidify on a frozen ice pack in the dark. Once the agarose blocks were 
fully hardened, the agarose blocks including the specimens were removed from the 
molds and placed in small glass jars, where they were treated overnight at 4 °C in the 
dark in sodium borohydride buffer (50mM sodium borohydride, 50mM borax, 50mM boric 
acid, pH 9.0-9.5). After overnight crosslinking, the agarose blocks were transferred to 
phosphate buffer for storage at 4 °C until TissueCyte imaging. In some samples, a pellet 
of e450+ B cells or unlabeled B cells was embedded next to the brain in the same 
agarose block in order to provide positive and negative control data for image analysis. 
 On the day of imaging, agarose blocks containing the brain samples were 
attached to a custom magnetic slide and with superglue then placed on a magnetized 
stage within an imaging chamber filled with phosphate buffer. STPT imaging is a block-
face imaging technique in which 2-dimensional (2D) mosaic images in the coronal plane 
are formed near the cut surface of the brain (within ~100 µm of the surface), followed by 
physical sectioning with a built-in vibrating microtome to cut away the imaged tissue, 
preparing a new cut surface for imaging (7). For this study, 2D mosaic images were 
taken at 25, 50, and 75 µm from the cut surface, followed by a vibrating microtome cut at 
75 µm (blade vibration frequency of 70 Hz, advancement velocity 0.5 mm/s). This 
process produced 570 2D mosaic images and 190 physical sections with a lateral 
resolution of 0.875 µm/pixel (~280 gigabytes of raw data per brain). The excitation laser 
(MaiTai DeepSee, SpectraPhysics/Newport, Santa Clara, CA) wavelength was 850 nm 
and was used to excite both YFP and eFluor450. Three image channels of emission 
fluorescence (pre-set bandpass filters encompassing “red,” “green,” and “blue” 
fluorophores) were collected with a predetermined photomultiplier tube voltage of 700 V. 
Individual tiles were adjusted via flat-field correction and stitched into 2D mosaic images 
of each imaging plane via custom software (“AutoStitcher,” TissueVision) and saved to 
network-attached storage drives.  
 
TissueCyte Image Analysis: 2D coronal images were transferred to a local computing 
cluster (“BioHPC”) via 10Gbit network. Custom software written in MATLAB (MathWorks, 
Natick, MA) was used to normalize intensity across all image (color) channels, forming a 
3-color, 3-dimensional (3D) image of each brain. Image stacks were denoised with a 3D 
median filter for visualization using open-source software tools including Vaa3D (8) and 
ImageJ/FIJI (9). Additional 3D visualization was facilitated via the ClearVolume plugin 
(10) for ImageJ/FIJI.  
 The 3D mouse brain images were registered to Allen Institute for Brain Science 
Common Coordinate Framework (11) (CCF version 3.0, update October 2017). 
Specifically, the “red” image channel of each 3D mouse brain image was downsampled 
to 10 µm square lateral voxels, converted to NIFTI format, then registered to the CCF 
“average template” (10 µm isotropic voxels). Registration was performed using the 
"NiftyReg software package (12, 13) using parameters similar to those used in the 
“aMAP” image analysis pipeline (14). Registration involved 3 main steps: (i) affine 
registration of experimental mouse brain to CCF average template (via the “reg-aladin” 
function of NiftyReg) (ii) cubic B-spline transformation (via “reg-f3d”) and (iii) resampling 
the transformed brains (via “reg-resample”). All 3 color channels were warped to the 
CCF using the registration information for the “red” color channel. Registered whole 
brain images were resampled to match pre-registration voxel sizes and converted to 16-
bit .tif format for further analysis. These analysis procedures were partially automated 
using a “nextflow” workflow implemented on the BioHPC cluster. 
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 Interactive, voxel-based supervised machine learning software (“Ilastik”; 
Reference DOI: 10.1109/ISBI.2011.5872394, 
https://ieeexplore.ieee.org/document/5872394/) was used to classify image features 
across the whole mouse brain, including labeled B cells. In brief, maximum intensity 
projection images of all full-resolution optical planes and color channels within a physical 
section were created and downsampled to 1.5 µm/pixel lateral resolution (creating a 
series of 190 3-color images from the 570 optical planes). From these images, 3-5 2D 
sections spanning the anterior-posterior axis of the brain were chosen for model training. 
The “Pixel Classification” applet in Ilastik, which implements voxel-based random forest 
machine learning, was used to interactively classify voxels belonging to five image 
features (“labels”): black background, tissue autofluorescence, noise (i.e. bright voxels 
resulting from imaging microbubbles in the tissue), injured tissue (characterized by 
dramatic alterations in the autofluorescence signature found in stroke samples) and blue 
cells (corresponding to labeled B cells). “Blue cell” classification was performed only on 
samples in which e450+ B cells had been injected, and were reinforced by training of 
e450+ B cell pellets embedded in the agarose adjacent to several samples. “Injured 
tissue” classification was performed only on tissue that had undergone tMCAo. 
“Autofluorescence,” “black background,” and “noise” was trained on sections from all 
experimental conditions. A unified random forest model based on representative images 
of all conditions was used to assign “probabilities” that each voxel in the whole brain 
images belonged to each label, resulting in a 5-channel “probability map” for each “label” 
for each experimental brain. Each 5-channel probability map was finally warped to CCF 
coordinates as per the above procedures.  
 A custom MATLAB script was used to quantify the normalized intensity of voxels 
within all annotated brain region for each of the 5 channels in the “probability map.” 
Normalization was performed by summing the per-channel intensities in each annotated 
region, then dividing by the total volume in the annotated region. This produced a matrix 
of normalized intensities for each channel and each annotated region for both 
hemispheres of the experimental samples. Because the CCF annotation has variable 
levels of parcellation depending on brain region, macroscopic brain regions of interest 
(e.g., striatum, hippocampus) were aggregated for simplicity based on the CCF 
parent/child hierarchical structure. 
 
Rotarod (Motor Coordination Test): The rotarod apparatus (IITC Life Science) 
consists of 5 semi-enclosed lanes and an elevated metal rod (1.25 in dia., 10 in 
elevation) with a fine textured finish to enhance grip. For each trial, all mice were placed 
on the unmoving rod, allowed to stabilize their posture, and then rod rotation was 
initiated. Test parameters were: rotation direction, toward investigator to encourage mice 
to face away while walking; start speed, 4 rpm; top speed, 44 rpm; acceleration rate, 0.2 
rpm/sec (200 sec. from start to top speed); max test duration, 300 sec. Each mouse’s 
trial ended when it either fell from the rod, triggering the fall-detection sensor, or gripped 
the rod without walking and thereby stayed on the rod for one full rotation (a “passive 
rotation”, in which case the investigator triggered the fall sensor manually). Data was 
automatically recorded to a computer. Mice that fell within 2 sec. were considered to 
have been startled by the initial rotation or “off-balance” at the start of the trial, and this 
data was excluded. Mice underwent 4 trials/day, and the average time from all 4 trials 
was taken. 
 
Novel object recognition: Each NO and NL task was comprised of three phases 
(habituation, familiarization, and testing) on separate days. All phases were performed in 
a blue-squared open-field box (44 x 44 x 30 cm.) under dim light condition (60 lux.) 
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between 10:00 and 14:00 hours. All mice tested were acclimated in the testing room 1 h. 
prior to testing. In the NO task, each mouse was habituated in the open-field box without 
objects for 15 min. each for two days (Days 1 and 2) and locomotor activity was 
assessed (15). Mice were positioned in the center of the box, and then individual total 
distance moved during the 15 min. of habituation was automatically recorded using a 
video tracking system (Noldus Information Technology). In the familiarization phase for 
NO task (Day 3), mice were subjected to a 1 min. re-habituation to the empty box and 
then placed in a holding cage. Immediately after, two identical objects (metal cones) 
were placed near the corners of the box and ~5 cm. from the walls. Mice were returned 
to the box for familiarization. They were allowed to freely explore until they accumulated 
a total of 30 sec. exploring both objects. Exploration was defined as the mouse 
contacting the object with its whiskers, nose, or front paws. We ensured that every 
mouse spent the same amount of time exploring the objects and avoided any bias due to 
differences in individual levels of exploration by removing the animal from the box once it 
had explored the objects for a total of 30 sec. Behaviors such as sitting on the object, 
looking around, or resting against the object were not counted as exploratory time. Once 
reaching the 30 sec. criteria, mice were then removed from the box and returned to their 
home cages. The mice that did not reach criteria within 15 min. were excluded from 
further testing. In the NO testing phase (Day 4), mice were subjected to a 1 min. re-
habituation to the empty box and then placed in a holding cage. Immediately after two 
objects, one of which was novel (doll) and the other was familiar (metal cone), were 
placed in the same location as during familiarization, mice were reintroduced into the 
box, and their exploratory behaviors were recorded by video camera for 10 min., and 
manually scored later. The position of the object used as novel or familiar in the NO 
were counter balanced across mice. 
 
Novel location recognition: In the NL task, each mouse was habituated in the open-
field box without objects for 15 min. (Day 8). In the familiarization phase for NL task (Day 
9), mice were subjected to a 1 min. re-habituation to the empty box then placed in a 
holding cage. Immediately after, two identical objects (3.5-inch binder clips) were placed 
in diagonal near the corners of the box (~5 cm from the walls) and mice were returned 
for familiarization. The mice were allowed to freely explore until they accumulated a total 
of 30 sec. exploring both objects. Once reaching the 30 sec. criteria, mice were then 
removed from the box and returned to their home cages. The mice that did not reach 
criteria within 15 min. were excluded from further testing. In the NL testing phase (Day 
10), mice were subjected to a 1 min. re-habituation to the empty box and then placed in 
a holding cage. Immediately after, the same two identical objects (3.5-inch binder clips), 
one of which was moved to a NL, were placed near the corners in the box, mice were 
reintroduced into the box and their exploratory behaviors were recorded by video 
camera for 10 min. and analyzed later. Time spent exploring each object for 10 min. was 
scored. To analyze cognitive performance, preference of NO or NL was calculated as 
time spent exploring the novel object or the familiar object in the novel location divided 
by the cumulative time spent exploring both objects. The open-field box was cleaned 
thoroughly with disinfectant solution after each trial to ensure the absence of olfactory 
cues. 
 
Contextual and cued fear conditioning: Fear conditioning was performed as 
previously described with slight modifications (16). For fear conditioning training (Day 
13), mice were placed in a Plexiglas shock box with clear front and rear walls 
(MedAssociates) for 2 min., and then a 30 sec., 90 dB acoustic tone co-terminating in a 
2 sec., 0.5 mA foot shock was delivered twice with a 1 min. inter-stimulus interval. 
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Freezing behavior was monitored at 4 sec. intervals by an observer blind to genotype or 
drug treatment. To test for hippocampal-dependent contextual fear response, mice were 
placed in the same context 24 h. following training (Day 14) and scored for freezing 
behavior every 4 sec. for 5 min. To test for hippocampal-independent cued fear 
response, mice were placed in a novel environment consisting of a Plexiglas floor, a 
roofed overhead, and a vanilla extract scent (Day 15). Mice were allowed to freely 
explore for 3 min. followed by a 90 dB acoustic tone for 3 min. Mice were scored for 
freezing behavior. 
 
Pain sensitivity: To determine whether there was any difference in pain sensitivity 
between the groups, foot shock sensitivity was measured by delivering a 2 sec. foot 
shock every 15 sec., starting at 0.05 mA. and increased by 0.05 mA. for each 
successive foot shock (Day 16). For each mouse, the lowest shock intensity that elicited 
a flinch, vocalization, or jump was scored. 
 
Immunohistochemistry (IHC): Immediately after the behavior test, all mice were 
sacrificed with isoflurane overdose and transcardially perfused with 4% 
paraformaldehyde as described previously (17, 18). All brains were cryoprotected in 
30% sucrose with 0.1% sodium azide prior to processing for immunohistochemistry 
(IHC). 30 µm. coronal sections spanning the entire hippocampus (-0.9 to -3.7 mm from 
Bregma) were collected at dry ice temperature on a microtome in a 1:6 series to allow 
for stereological quantification. Hippocampal sections were mounted onto coded 
superfrost-plus slides (Fisher Scientific) and were allowed to dry for 2 h. (17, 18). After 
drying, sections were first incubated in 0.01M. citric acid (pH 6.0, 100ºC) for 15 minutes 
for antigen retrieval. Sections stained for BrdU underwent 2 additional pretreatment 
steps: permeabilization with trypsin and 0.1% CaCl2 in 0.1M Tris. pH 7.4 (10 min), and 
denaturation with 2N HCl (30 min.) (18). All slides were then incubated in 0.3% H2O2 to 
quench endogenous peroxidases. Nonspecific binding was blocked with 3% normal 
donkey serum and 0.3% Triton-X 100 in 1X PBS for 1 h. The following primary 
antibodies were used: rat monoclonal anti-BrdU (1:400; Accurate) and goat polyclonal 
anti-DCX (1:500; Santa Cruz Biotechnology). Primary antibody incubation was followed 
by 2 h. incubation in the appropriate biotin-conjugated secondary antibody and 90 min. 
in ABC (1:50; Vector Laboratories). BrdU+ and DCX+ cells were visualized with 
DAB/metal concentrate (10x; Thermo Scientific). After immunostaining, sections were 
counterstained with Nuclear Fast Red (Vector Laboratories), dehydrated with graded 
ethanol, and cover slipped using DPX (Fluka). To minimize variability and add 
quantification of resulting stains, tissues from all mice in a cohort were processed 
through IHC simultaneously. 
 
Brightfield microscopic cell quantification: Following IHC on hippocampal sections, 
unbiased estimates for DCX cell counts were obtained using stereological quantification 
on an Olympus BX51 System Microscope with a MicroFIRE A/R camera (Optronics) as 
previously published (17). Estimation of total DCX+ cell number was performed using the 
Optical Fractionator Probe within the Stereo Investigator software (MBF Bioscience) 
according to previously published stereological methods (19). An unbiased counting 
frame superimposed on the region of interest was used to quantify cell number. 
Counting was performed using a 40x, 0.63 NA lens. At least 250 cells per mouse were 
counted, and the average number of counting fields per mouse was close to 300. The 
average number of sections per mouse counted was 10. To decrease the effect of 
shrinkage on the tissue, the average measured mounting thickness after processing was 
approximately 22µm. and we used an optical dissector height of 14µm. The area-
 
 
8 
 
sampling fraction was 1/25 and every 6th section (section sampling fraction) was used to 
quantify DCX+ cells within the GCL of the dentate gyrus. The Gunderson coefficient of 
variance for each mouse quantified was always less than 10%.  Data are reported as the 
total number of DCX+ cells in the GCL per brain.  
 
BrdU Labeling and Quantification: At the beginning of the neurogenesis studies, all 
mice received three intraperitoneal (i.p.) injections of bromodeoxyuridine (BrdU; 
150mg/kg dissolved in 0.9% saline and 0.007 N NaOH; one injection every 6 h) to label 
dividing cells in S-phase. (18) Bright field staining of coded slides was visualized with an 
Olympus BX51 microscope using a 40x, 0.63 NA lens with continuous adjustment 
through the depth of the section as described previously. (18) Using stereological 
principles,(17) staining was examined and immunoreactive cells were quantified in the 
SGZ of the hippocampal dentate gyrus. The SGZ was defined as a region straddling the 
border of the GCL and the hilus: 30µm into the hilus and the inner half of the GCL 
adjacent to the hilus (17). Exhaustive counts for BrdU+ cells were undertaken using the 
optical fractionator method in which every 6th section spanning the entire anterior-
posterior hippocampus was examined (-0.6 to -4.8 mm from Bregma). The section 
sampling fraction was 1/6 and the resulting number of BrdU-positive (BrdU+) cells was 
multiplied by 6 and reported as total number of cells in the SGZ per brain. Because the 
raw counts (before multiplication) for the immunoreactive cells counted here were low 
according to dissector / fractionator standards (20, 21), we used an area sampling 
fraction of 1 as is commonly used for counting rare cell populations (17) Based on 
previous work from our laboratory and those of others, (17, 22, 23) the height sampling 
fraction was set at 1. All cell quantification was done in a blinded fashion. 
 
Granule Cell Layer quantification: Volume estimation of the granule cell layer (GCL) of 
the dentate gyrus was performed using the Cavalieri Probe within Stereo Investigator as 
previously described (17). The GCL was viewed and volume determined using an 
Olympus BX51 microscope with a 10x, NA 0.30 lens. Area sizes from every 6th section 
were determined using the area measurement tool (based on the Cavalieri estimator) in 
which an automated grid of test points was superimposed upon the region of interest. 
The area of the GCL was estimated from the total number of points that fell within the 
field. To obtain the volume, the sum of the areas measured was multiplied by the 
sampling fraction (21) and the section thickness (30 µm). The Gunderson coefficient of 
variance for each mouse quantified was always less than 10%. Data are reported as the 
total estimated volume (µm3) of the GCL per brain. 
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Supplemental Figures: 
 
Fig. S1. Rotarod and force grip is unaltered in B cell-treated mice. PBS- and wild 
type (WT) B cell-treated cohorts exhibited the same rate of recovery as assessed on (A) 
rotarod for motor coordination or (B) force grip device for muscle strength. (C) Infarct 
volumes quantified from serial MRI images show that the adoptive transfer of WT B cells 
(green upward triangles) significantly decreases infarct volumes 3 and 7 days post-
stroke, as compared to control PBS (black circles) or repetitive hypoxic preconditioning 
(RHP)-modulated B cells (downward blue triangles). WT and PBS cohorts are also 
shown in Figure 1. (D) PBS- and WT B cell-treated cohorts exhibited the same rate of 
recovery as assessed on rotarod (also panel A), while the B(RHP) cell-treated cohort 
displayed motor deficits that persisted through 2 weeks after tMCAo. A,D: *p<0.05, 
**p<0.01, ***p<0.001 vs. pre-stroke baseline. C: *p<0.05 vs. PBS.  
  
 
 
10 
 
 
 
Fig. S2. Representative images of mixed cortical cultures with IL-10-deficient B 
cells. Panels depict 10X images of microtubule-associated protein (MAP2)+ neurons 
(red) for treatment (txn) groups shown in Figure 2E,2F, with higher magnification inset. 
Ratios of B cells to mixed cortical cells are depicted in the lower right corner of each 
panel for untreated (left images) and IL-10-deficient B cell-treated (right images) groups 
in both Non-oxygen glucose deprivation (OGD) groups (top panels) and OGD-treated 
groups (bottom panels). Scale bar = 50 µm 
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Fig. S3. Confirmation of e450+ B cells in systemic circulation. (A) Flow plots from 
CD45+ leukocyte populations (far right plots) for PBS-treated (top row) and e450+ B cell-
treated (bottom row) mice. CD19+ B cells (y axes) labeled with e450 (x axes) are only in 
the spleens and cervical lymph nodes (CLN) of B cell recipients. Absolute (B) splenic 
and (C) CLN counts for e450+ B cells in each recipient hCD20+ mouse (red circles). (D, 
E) Confirmation of e450+ B cells in B cell-depleted mice (red triangles) compared to mice 
with endogenous B cells (black triangles). While (D) percent representation was greatly 
diminished in the presence of endogenous B cells, (E) cell numbers were similar. 
*p<0.05, ****p<0.0001 compared to B cell-depleted cohort. 
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Fig. S4. Genotype does not affect motor learning prior to stroke or muscle 
strength after stroke. (A) Successfully-depleted CD20+ cells was confirmed by 
significant reduction of CD19+ cells in the spleen of transgenic human (h)CD20+ 
transgenic mice (red squares) compared to wild type (WT) littermate controls (black 
circles). (B) hCD20+ mice (i.e. B cell-depleted) and WT hCD20- mice did not exhibit any 
differences in motor learning on the rotarod over 8 pre-stroke training sessions. 
Rituximab (Ritux) was given on the 7th day of training, and two consecutive days over 
the weekend prior to the 8th day of training. (C) Upper extremity force grip was measured 
for two days prior to transient middle cerebral artery occlusion (tMCAo), then for 4 days 
post-tMCAo. There was no effect of genotype on the initial loss of grip strength, or 
subsequent recovery after post-tMCAo, for B cell-depleted mice (red squares) compared 
to B cell(+) mice (black circles). Mean ± standard deviation (SD) shown. *p<0.05; *** 
p<0.001; **** p<0.0001.  
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Fig. S5. B cell depletion did not affect non-stressful cognitive function. (A) 
Rituximab treatment in transgenic human (h)CD20+ transgenic mice (red squares) and 
wild type (WT) littermate controls (black circles) show reductions in B cell representation 
for both naïve mice and mice that had a transient middle cerebral artery occlusion 
(tMCAo). (B-G) Long-term cognitive function was simultaneously acquired in four 
cohorts for transgenic human hCD20+ mice and littermate hCD20- wild type (WT) mice 
(black circles) under either healthy, naïve condition (clear bars) or following transient 
middle cerebral artery occlusion (tMCAo; grey bars). (B) Open field movement in naïve 
mice had a similar day 2 decline as post-tMCAo mice shown in Figure 2. There was a 
similar response in all four cohorts for the amount of time exploring (C) the novel object, 
as well as (D) preference for the novel object. This was also true for cumulative 
exploration time within the (E) novel location, as well as (F) preference for the novel 
location. (G) However, on the first day of fear-conditioning, post-stroke B cell-depleted 
mice exhibited prolonged freezing during the training tones/shocks after the final tone. 
Mean ± standard deviation (SD) shown. *p<0.05 
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Fig. S6. Long-term B cell depletion in uninjured mice. (A) B cell depletion did not 
alter granule cell layer (GCL) volume in the dentate gyrus in the absence of stroke, 
matching neurogenesis data shown in Fig. 7B (B) B cell depletion did not affect 
bromodeoxyuridine (BrdU)+ cells in the dentate gyrus between hemisphere in the 
absence of stroke. Two-way ANOVA.  
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